Inhibitors of Acetylcholinesterase Derived from 7-Methoxytacrine and Their Effects on the Choline Transporter CHT1

Publisher： Karger

E-ISSN： 1421-9824|43|1-2|45-58

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.43, Iss.1-2, 2016-12, pp. : 45-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Differential Effects of Acetylcholinesterase Inhibitors on Clinical Responses and Cerebral Blood Flow Changes in Patients with Alzheimer's Disease: A 12-Month, Randomized, and Open-Label Trial

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 5, Iss. 1, 2015-04 ,pp. : 135-146

Karger

Access to resources Recommend Favorite

Comedication and Treatment Length in Users of Acetylcholinesterase Inhibitors


By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 7, Iss. 1, 2017-02 ,pp. : 30-40

Karger

Access to resources Recommend Favorite

Genetic, Epigenetic and Biological Effects of Zinc Transporter (SLC30A8) in Type 1 and Type 2 Diabetes

By  

Current Diabetes Reviews, Vol. 13, Iss. 2, 2017-02 ,pp. : 132-140

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Can Glucagon Like Peptide 1 (GLP1) Agonists or Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors Ameliorate Non-Alcoholic Steatohepatitis in People with or without Diabetes?

By  

Current Vascular Pharmacology, Vol. 14, Iss. 6, 2016-10 ,pp. : 494-497

Bentham Science Publishers

Access to resources Recommend Favorite

Vesicular Acetylcholine Transporter (VAChT) in the Brain of Spontaneously Hypertensive Rats (SHR): Effect of Treatment with an Acetylcholinesterase Inhibitor

By Tayebati S. K.   Di Tullio M.A.   Amenta F.  

Clinical and Experimental Hypertension, Vol. 30, Iss. 8, 2008-11 ,pp. : 732-743

Informa Healthcare

Access to resources Recommend Favorite